Atlas Trials

Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

Clinical trial NCT00994253 · WITHDRAWN

Trial details

NCT number
NCT00994253
Sponsor
Corewell Health East
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
HypertensionDiabetes Type 2
Start date
2009-08-01
Primary completion
2012-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.